These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31732192)

  • 1. Structural bases that underline Trypanosoma cruzi calreticulin proinfective, antiangiogenic and antitumor properties.
    Peña Álvarez J; Teneb J; Maldonado I; Weinberger K; Rosas C; Lemus D; Valck C; Olivera-Nappa Á; Asenjo JA; Ferreira A
    Immunobiology; 2020 Jan; 225(1):151863. PubMed ID: 31732192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi Calreticulin: Immune Evasion, Infectivity, and Tumorigenesis.
    Ramírez-Toloza G; Sosoniuk-Roche E; Valck C; Aguilar-Guzmán L; Ferreira VP; Ferreira A
    Trends Parasitol; 2020 Apr; 36(4):368-381. PubMed ID: 32191851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta.
    Castillo C; Ramírez G; Valck C; Aguilar L; Maldonado I; Rosas C; Galanti N; Kemmerling U; Ferreira A
    PLoS Negl Trop Dis; 2013; 7(8):e2376. PubMed ID: 23991234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.
    Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C
    Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable numbers of calreticulin genes in Trypanosoma cruzi correlate with atypical morphology and protein expression.
    González A; Härtel S; Mansilla J; Sánchez-Valdéz F; Ferreira A
    Immunobiology; 2018 Dec; 223(12):802-806. PubMed ID: 30131175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence.
    Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Ferreira VP; Ferreira A
    Front Immunol; 2020; 11():1561. PubMed ID: 32793217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin.
    Valck C; Ramírez G; López N; Ribeiro CH; Maldonado I; Sánchez G; Ferreira VP; Schwaeble W; Ferreira A
    Mol Immunol; 2010 Apr; 47(7-8):1516-21. PubMed ID: 20153898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin.
    López NC; Valck C; Ramírez G; Rodríguez M; Ribeiro C; Orellana J; Maldonado I; Albini A; Anacona D; Lemus D; Aguilar L; Schwaeble W; Ferreira A
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e730. PubMed ID: 20625551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth.
    Ramírez G; Valck C; Aguilar L; Kemmerling U; López-Muñoz R; Cabrera G; Morello A; Ferreira J; Maya JD; Galanti N; Ferreira A
    Mol Immunol; 2012 Oct; 52(3-4):133-40. PubMed ID: 22673211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is It Possible to Intervene in the Capacity of
    Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A
    Front Immunol; 2021; 12():789145. PubMed ID: 34975884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.
    Sosoniuk-Roche E; Vallejos G; Aguilar-Guzmán L; Pizarro-Bäuerle J; Weinberger K; Rosas C; Valck C; Michalak M; Ferreira A
    Immunobiology; 2017 Mar; 222(3):529-535. PubMed ID: 27839837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?
    Ramírez-Toloza G; Abello P; Ferreira A
    Front Immunol; 2016; 7():268. PubMed ID: 27462315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Trypanosoma cruzi calreticulin modulate the complement system and angiogenesis?
    Ferreira V; Molina MC; Schwaeble W; Lemus D; Ferreira A
    Trends Parasitol; 2005 Apr; 21(4):169-74. PubMed ID: 15780838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi.
    Ferreira V; Valck C; Sánchez G; Gingras A; Tzima S; Molina MC; Sim R; Schwaeble W; Ferreira A
    J Immunol; 2004 Mar; 172(5):3042-50. PubMed ID: 14978109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo role for Trypanosoma cruzi calreticulin in antiangiogenesis.
    Molina MC; Ferreira V; Valck C; Aguilar L; Orellana J; Rojas A; Ramirez G; Billetta R; Schwaeble W; Lemus D; Ferreira A
    Mol Biochem Parasitol; 2005 Apr; 140(2):133-40. PubMed ID: 15760653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity.
    Ramírez G; Valck C; Molina MC; Ribeiro CH; López N; Sánchez G; Ferreira VP; Billetta R; Aguilar L; Maldonado I; Cattán P; Schwaeble W; Ferreira A
    Immunobiology; 2011; 216(1-2):265-73. PubMed ID: 20472323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro Treatment of a Murine Mammary Adenocarcinoma Cell Line with Recombinant Trypanosoma cruzi Calreticulin Promotes Immunogenicity and Phagocytosis.
    Sosoniuk-Roche E; Cruz P; Maldonado I; Duaso L; Pesce B; Michalak M; Valck C; Ferreira A
    Mol Immunol; 2020 Aug; 124():51-60. PubMed ID: 32526557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi Calreticulin Topographical Variations in Parasites Infecting Murine Macrophages.
    González A; Valck C; Sánchez G; Härtel S; Mansilla J; Ramírez G; Fernández MS; Arias JL; Galanti N; Ferreira A
    Am J Trop Med Hyg; 2015 May; 92(5):887-97. PubMed ID: 25758653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does native Trypanosoma cruzi calreticulin mediate growth inhibition of a mammary tumor during infection?
    Abello-Cáceres P; Pizarro-Bauerle J; Rosas C; Maldonado I; Aguilar-Guzmán L; González C; Ramírez G; Ferreira J; Ferreira A
    BMC Cancer; 2016 Sep; 16(1):731. PubMed ID: 27619675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.